@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
sub:version prov:value "1"^^xsd:integer .
rdf:object ns1:C0003280 "anticoagulant";
ns1:C0016055 "fibronectin";
ns1:C0086597 "mediated";
ns1:C0127400 "mediated";
ns1:C0205217 "augment";
ns1:C1280500 "effects";
ns1:C1570610 "fibronectin";
ns1:C2986495 "synergistic";
ns1:C3536711 "anticoagulant" .
rdf:predicate ns3:TRIPLE_UID:1jnziuot-TRIPLE-ABSTRACT-21 "exert" .
rdf:subject ns1:C0011777 "dexamethasone" .
rdfs:Triple-UID ns2:TRIPLE_UID:1jnziuot-TRIPLE-ABSTRACT-21 "1jnziuot-TRIPLE-ABSTRACT-21" .
rdfs:sentence rdfs:label "we's studies demonstrated that LABAs and dexamethasone exert synergistic effects that will augment both anti-inflammatory and fibronectin-mediated anticoagulant effects." .
rdfs:triple rdfs:label "LABAs and dexamethasone exert synergistic effects that will augment both anti - inflammatory and fibronectin - mediated anticoagulant effects" .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:46:41.041455"^^xsd:dateTime .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "Ux6FYIbXXnk8KxxtrZ0SpywsdewHmk26x/4sf9wWvZxY03HdOc/uvkSsaoftREF+OnhRhYwfalbej6AwrajxcprnTVBr/NwJow9tEyzevMpAK87JcoUiWHKEqY2an4jB6auPPtpyn9M7GQ30Yz1RJqFQUJDEa5Q4gK9FpTH1ALw=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-07-25T21:46:41.041455"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}